- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
股价的强势特征已经确立，短线可能回调。
- 中期趋势：
上涨趋势有所减缓，可适量高抛低吸。
- 长期趋势：
已有230家主力机构披露2025-12-31报告期持股数据，持仓量总计1.99亿股，占流通A股44.39%
- 波段诊断：
-
技术面诊股
诊断结果：6.9技术面打败了78%的股票
技术面评分前10的股票
近期的平均成本为43.42元。多头行情中，上涨趋势有所减缓，可适量做高抛低吸。
平均成本
近期的平均成本为43.42元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"43.42","date":1776933702,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势接近大盘，明显跑赢行业平均水平。
[{"date":"2026.04.24","stock":"1.36","trade":"0.07","ind":"-0.33"},{"date":"2026.04.23","stock":"3.14","trade":"-1.89","ind":"-0.32"},{"date":"2026.04.22","stock":"1.37","trade":"1.12","ind":"0.52"},{"date":"2026.04.21","stock":"-0.68","trade":"-1.11","ind":"0.07"},{"date":"2026.04.20","stock":"-0.34","trade":"0.69","ind":"0.76"},{"date":"2026.04.17","stock":"-1.01","trade":"-1.80","ind":"-0.10"},{"date":"2026.04.16","stock":"0.63","trade":"-0.04","ind":"0.70"},{"date":"2026.04.15","stock":"-0.51","trade":"0.14","ind":"0.01"},{"date":"2026.04.14","stock":"0.24","trade":"1.73","ind":"0.95"},{"date":"2026.04.13","stock":"-1.54","trade":"-1.22","ind":"0.06"},{"date":"2026.04.10","stock":"0.74","trade":"0.70","ind":"0.51"},{"date":"2026.04.09","stock":"-1.51","trade":"-1.86","ind":"-0.72"},{"date":"2026.04.08","stock":"3.13","trade":"2.51","ind":"2.70"},{"date":"2026.04.07","stock":"0.44","trade":"0.66","ind":"0.26"},{"date":"2026.04.03","stock":"-1.35","trade":"-3.06","ind":"-1.00"},{"date":"2026.04.02","stock":"-2.19","trade":"-0.64","ind":"-0.74"},{"date":"2026.04.01","stock":"0.97","trade":"5.25","ind":"1.46"},{"date":"2026.03.31","stock":"0.48","trade":"0.22","ind":"-0.80"},{"date":"2026.03.30","stock":"-0.14","trade":"1.19","ind":"0.24"},{"date":"2026.03.27","stock":"3.33","trade":"4.12","ind":"0.63"},{"date":"2026.03.26","stock":"-1.41","trade":"-0.95","ind":"-1.09"}]
通策医疗,上证指数,医疗服务指数
压力支撑
该股压力位为43.02元，支撑位为41.64元。
[{"text":"\u538b\u529b\u4f4d","value":"43.02","date":1776960000,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"41.64","date":1776960000,"color":"0x0b52a1"}]
多空趋势
多头行情中，上涨趋势有所减缓，可适量做高抛低吸。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：3.1资金面打败了25%的股票
主力控盘前10的股票
行业资金
医疗服务行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：04月24日 20:31
| 机构今日流向(万元) | 241.22 | 机构5日流向(万元) | -3591.99 |
| 机构10日流向(万元) | -8994.97 | 机构20日流向(万元) | -6762.52 |
机构持仓
2025-12-31 与 2025-06-30 相比，主力机构持仓量减少2326.73万股，其中基金净减仓84家，主力净减仓29家，请投资者中长期谨慎为宜。
截止2025-12-31，共230家主力机构（基金227家，一般法人3家），持仓量总计19856.67万股，占流通A股44.39%
其中，基金持仓与2025-06-30相比：
增仓：36家 ，增持 157.76万股
减仓：120家 ，减持 766.78万股
新出现在主力名单中：55家 ，持有169.06万股
从主力名单中消失：84家 ，原持有1428.74万股
其中，基金持仓与2025-06-30相比：
增仓：36家 ，增持 157.76万股
减仓：120家 ，减持 766.78万股
新出现在主力名单中：55家 ，持有169.06万股
从主力名单中消失：84家 ，原持有1428.74万股
消息面诊股
诊断结果：5.8消息面打败了44%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- DeepSeek-V4预览版本正式上线并同步开源
2026-04-24 - 通策医疗：4月23日获融资买入1.56亿元
2026-04-24 - 机构评级|2家机构更新通策医疗评级
2026-04-23 - 国金证券：给予通策医疗增持评级
2026-04-23 - 通策医疗：4月22日获融资买入1724.15万元
2026-04-23 - 通策医疗：4月21日获融资买入2522.57万元
2026-04-22 - 通策医疗获6家机构调研：临床端作为医生副驾驶，辅助
2026-04-22 - 通策医疗：目前浙江省尚未正式出台价格指南
2026-04-21 - 通策医疗：公司将种植牙业务视为口腔医院集团应做的基
2026-04-21 - 通策医疗：2025年蒲公英医院共49家，实现收入8
2026-04-21
消息列表
| 一般消息 | 分红转增 | 不分配不转增 | 2026-04-18 |
| 一般消息 | 重大事项 | 关联交易 | 2026-04-18 |
| 一般消息 | 股东大会 | 临时股东大会 | 2026-03-25 |
| 一般消息 | 募资投向 | 公司购买资产 | 2026-03-25 |
| 一般消息 | 重大事项 | 关联交易 | 2026-03-25 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-12-31 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-12-10 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-11-12 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-10-24 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-09-17 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-09-12 |
| 一般消息 | 重大事项 | 关联交易 | 2025-08-29 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-23 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-08-06 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-07-19 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-07-12 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-06-30 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-05-17 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-05-10 |
| 利好 | 分红转增 | 10派4.5元(含税) | 2025-04-26 |
| 一般消息 | 重大事项 | 关联交易 | 2025-04-26 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 3条 | 0条 | 3条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：5.5行业面打败了69%的股票
医疗服务行业最新资金流向
近10日来该行业走势不明显，明显跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，明显跑输大盘。
[{"date":"2026.04.24","price":"-0.33","value":"0.07"},{"date":"2026.04.23","price":"-0.32","value":"-1.89"},{"date":"2026.04.22","price":"0.52","value":"1.12"},{"date":"2026.04.21","price":"0.07","value":"-1.11"},{"date":"2026.04.20","price":"0.76","value":"0.69"},{"date":"2026.04.17","price":"-0.10","value":"-1.80"},{"date":"2026.04.16","price":"0.70","value":"-0.04"},{"date":"2026.04.15","price":"0.01","value":"0.14"},{"date":"2026.04.14","price":"0.95","value":"1.73"},{"date":"2026.04.13","price":"0.06","value":"-1.22"},{"date":"2026.04.10","price":"0.51","value":"0.70"},{"date":"2026.04.09","price":"-0.72","value":"-1.86"},{"date":"2026.04.08","price":"2.70","value":"2.51"},{"date":"2026.04.07","price":"0.26","value":"0.66"},{"date":"2026.04.03","price":"-1.00","value":"-3.06"},{"date":"2026.04.02","price":"-0.74","value":"-0.64"},{"date":"2026.04.01","price":"1.46","value":"5.25"},{"date":"2026.03.31","price":"-0.80","value":"0.22"},{"date":"2026.03.30","price":"0.24","value":"1.19"},{"date":"2026.03.27","price":"0.63","value":"4.12"},{"date":"2026.03.26","price":"-1.09","value":"-0.95"}]
上证指数,医疗服务行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 药康生物 | 41.25% | 5.67% | 6.6分 |
| 2 | 昭衍新药 | 36.81% | 1.84% | 5.1分 |
| 3 | 普瑞眼科 | 29.15% | 15.04% | 6.5分 |
| 4 | 美迪西 | 24.98% | -0.22% | 6.0分 |
| 5 | 百奥赛图 | 24.81% | 4.28% | 6.6分 |
| 6 | 泓博医药 | 23.99% | 8.24% | 6.0分 |
| 8 | 益诺思 | 17.40% | -0.47% | 5.2分 |
| 10 | 康龙化成 | 14.19% | -4.10% | 4.9分 |
| 12 | 成都先导 | 12.90% | -2.45% | 5.2分 |
| 14 | 金域医学 | 11.73% | 3.89% | 5.4分 |
| 16 | 诺思格 | 10.87% | -1.65% | 6.1分 |
| 18 | 华厦眼科 | 10.07% | 6.46% | 6.1分 |
| 20 | 博济医药 | 9.57% | 0.00% | 4.9分 |
| 22 | 皓元医药 | 8.64% | -3.36% | 5.2分 |
| 24 | 毕得医药 | 6.16% | -7.35% | 5.1分 |
| 26 | 普蕊斯 | 5.89% | -3.61% | 4.9分 |
| 28 | 药明康德 | 5.65% | 0.69% | 5.9分 |
| 30 | 迪安诊断 | 4.83% | -1.20% | 5.3分 |
| 32 | 何氏眼科 | 3.89% | 3.13% | 5.7分 |
| 34 | ST中珠 | 2.54% | -4.07% | 5.0分 |
| 36 | 和元生物 | 1.52% | -4.86% | 4.6分 |
| 38 | 华大基因 | -0.54% | -2.66% | 4.6分 |
| 40 | 诚达药业 | -1.97% | -3.82% | 4.3分 |
| 42 | 光正眼科 | -2.81% | 2.72% | 5.8分 |
| 44 | 贝瑞基因 | -3.68% | -3.78% | 4.6分 |
| 46 | 阳光诺和 | -4.58% | -8.66% | 4.5分 |
| 48 | 皓宸医疗 | -5.60% | 2.43% | 4.6分 |
| 50 | 海特生物 | -6.12% | -3.98% | 4.6分 |
| 52 | 百花医药 | -7.05% | -2.47% | 4.8分 |
| 54 | 大湖股份 | -7.46% | -2.82% | 4.9分 |
| 56 | 盈康生命 | -7.67% | -5.22% | 5.2分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 安信证券 | 2012-09-04 | 增持 | 增持 |
| 长江证券 | 2012-09-02 | 增持 | - |
更多>>行业资讯
- 2012-09-13北京药监局通知全市停用8家企业中药饮片
- 2012-09-13澳洲股指周四收跌0.5% 医疗及消费股领跌
- 2012-09-13基层中医药服务能力将获提升
- 2012-09-132012中国医疗卫生产业发展论坛召开
- 2012-09-13医药行业：媒体称新版基药目录品种将扩至700个
- 2012-09-13陕西县级公立医院改革全面推开
- 2012-09-138月中山CPI 环比涨0.1%
- 2012-09-13中金公司：医药板块选股坚持“稳健业绩+成长空间预期
- 2012-09-13澳洲股指周四盘初跌0.5% 医疗及消费股领跌
- 2012-09-13感冒药“实名制”个人信息易“走光”？ 法国立法严管
基本面诊股
[ 截止日期：2026-03-31 ]公司经营
盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 2/102 ， 5/102。
[{"date":"2026-03-31","value":"4.32","vol":"1.27"},{"date":"2025-12-31","value":"12.15","vol":"4.03"},{"date":"2025-09-30","value":"12.27","vol":"3.24"},{"date":"2025-06-30","value":"7.85","vol":"2.24"},{"date":"2025-03-31","value":"4.47","vol":"0.90"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
4.32 | 12.15 | 12.27 | 7.85 | 4.47 |
| 行业(%) | 1.27 | 4.03 | 3.24 | 2.24 | 0.90 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"43.87","vol":"36.80"},{"date":"2025-12-31","value":"38.63","vol":"34.45"},{"date":"2025-09-30","value":"41.69","vol":"36.06"},{"date":"2025-06-30","value":"40.75","vol":"36.21"},{"date":"2025-03-31","value":"44.21","vol":"34.35"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
43.87 | 38.63 | 41.69 | 40.75 | 44.21 |
| 行业(%) | 36.80 | 34.45 | 36.06 | 36.21 | 34.35 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 9/102 ， 7/102。
[{"date":"2026-03-31","value":"1.43","vol":"0.47"},{"date":"2025-12-31","value":"1.37","vol":"4.47"},{"date":"2025-09-30","value":"2.56","vol":"3.06"},{"date":"2025-06-30","value":"2.68","vol":"2.87"},{"date":"2025-03-31","value":"5.11","vol":"-0.74"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
1.43 | 1.37 | 2.56 | 2.68 | 5.11 |
| 行业(%) | 0.47 | 4.47 | 3.06 | 2.87 | -0.74 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"1.66","vol":"56.08"},{"date":"2025-12-31","value":"0.19","vol":"-5.79"},{"date":"2025-09-30","value":"3.16","vol":"20.05"},{"date":"2025-06-30","value":"3.67","vol":"-63.31"},{"date":"2025-03-31","value":"6.22","vol":"-22.48"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
1.66 | 0.19 | 3.16 | 3.67 | 6.22 |
| 行业(%) | 56.08 | -5.79 | 20.05 | -63.31 | -22.48 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 3/102 ， 2/102。
[{"date":"2026-03-31","value":"0.12","vol":"0.09"},{"date":"2025-12-31","value":"0.48","vol":"0.43"},{"date":"2025-09-30","value":"0.37","vol":"0.32"},{"date":"2025-06-30","value":"0.23","vol":"0.21"},{"date":"2025-03-31","value":"0.12","vol":"0.10"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.12 | 0.48 | 0.37 | 0.23 | 0.12 |
| 行业(次) | 0.09 | 0.43 | 0.32 | 0.21 | 0.10 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"18.93","vol":"5.68"},{"date":"2025-12-31","value":"71.86","vol":"18.81"},{"date":"2025-09-30","value":"42.81","vol":"10.95"},{"date":"2025-06-30","value":"28.10","vol":"7.15"},{"date":"2025-03-31","value":"14.17","vol":"3.69"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
18.93 | 71.86 | 42.81 | 28.10 | 14.17 |
| 行业(次) | 5.68 | 18.81 | 10.95 | 7.15 | 3.69 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2026-03-31","value":"21.31","vol":"2.22"},{"date":"2025-12-31","value":"20.73","vol":"20.81"},{"date":"2025-09-30","value":"38.71","vol":"16.52"},{"date":"2025-06-30","value":"29.57","vol":"15.83"},{"date":"2025-03-31","value":"19.84","vol":"-1.06"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 21.31 | 20.73 | 38.71 | 29.57 | 19.84 |
| 行业 | 2.22 | 20.81 | 16.52 | 15.83 | -1.06 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"0.93","vol":"1.00"},{"date":"2025-09-30","value":"","vol":"0.01"},{"date":"2025-06-30","value":"1.11","vol":"0.91"},{"date":"2025-03-31","value":"","vol":"0.00"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.93 | - | 1.11 | - |
| 行业 | 0.00 | 1.00 | 0.01 | 0.91 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 5/102 ， 6/102。
[{"date":"2026-03-31","value":"1.71","vol":"3.62"},{"date":"2025-12-31","value":"1.49","vol":"3.52"},{"date":"2025-09-30","value":"1.62","vol":"3.67"},{"date":"2025-06-30","value":"1.28","vol":"3.57"},{"date":"2025-03-31","value":"1.61","vol":"3.75"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 流动比率 |
1.71 | 1.49 | 1.62 | 1.28 | 1.61 |
| 行业 | 3.62 | 3.52 | 3.67 | 3.57 | 3.75 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"1.58","vol":"3.03"},{"date":"2025-12-31","value":"1.38","vol":"2.82"},{"date":"2025-09-30","value":"1.47","vol":"2.94"},{"date":"2025-06-30","value":"1.15","vol":"2.87"},{"date":"2025-03-31","value":"1.48","vol":"3.03"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 速动比率 |
1.58 | 1.38 | 1.47 | 1.15 | 1.48 |
| 行业 | 3.03 | 2.82 | 2.94 | 2.87 | 3.03 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 9/102 ， 9/102。
[{"date":"2026-03-31","value":"23.29","vol":"31.82"},{"date":"2025-12-31","value":"24.38","vol":"33.93"},{"date":"2025-09-30","value":"25.10","vol":"32.60"},{"date":"2025-06-30","value":"27.51","vol":"33.58"},{"date":"2025-03-31","value":"26.97","vol":"32.64"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
23.29 | 24.38 | 25.10 | 27.51 | 26.97 |
| 行业(%) | 31.82 | 33.93 | 32.60 | 33.58 | 32.64 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.33","vol":"0.64"},{"date":"2025-12-31","value":"0.35","vol":"1.15"},{"date":"2025-09-30","value":"0.36","vol":"0.92"},{"date":"2025-06-30","value":"0.41","vol":"0.96"},{"date":"2025-03-31","value":"0.40","vol":"0.97"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.33 | 0.35 | 0.36 | 0.41 | 0.40 |
| 行业(%) | 0.64 | 1.15 | 0.92 | 0.96 | 0.97 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中泰证券 | 2026-04-23 | 增持 | |
| 国金证券 | 2026-04-22 | 增持 | |
| 华泰证券 | 2026-04-22 | 买入 | 买入 |
| 开源证券 | 2026-04-21 | 买入 | |
| 国联民生 | 2026-04-21 | 买入 | |
| 东吴证券 | 2026-04-20 | 买入 |
机构预测
机构预测该股2026年每股收益与前一年相同，长期投资价值一般。
[{"date":"2022","yellowRectValue":"5.48","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"5.00","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"5.01","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"5.02","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"5.96","blueLineValue":"1.33","type":"YC"}]